Keudell/Morrison Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
CRM
VNIM
CNB
Keudell/Morrison Wealth Management's LLY Position: Q2 2026 in Review
Keudell/Morrison Wealth Management increased its Eli Lilly (LLY) stake by 0.65% in Q2 2026, buying an estimated $32.7K and bringing the position to 4,989 shares worth $5.98M. The position accounts for 1.13% of the portfolio, ranked #19.
Keudell/Morrison Wealth Management first reported a position in LLY in Q1 2019 and has held it in 29 quarters since. 873 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Keudell/Morrison Wealth Management held 4,989 shares of Eli Lilly worth $5.98M as of Q2 2026.
- Keudell/Morrison Wealth Management bought 32 Eli Lilly shares in Q2 2026, an estimated $32.7K.
- Eli Lilly made up 1.13% of Keudell/Morrison Wealth Management's portfolio in Q2 2026, its #19 holding.
- Keudell/Morrison Wealth Management first reported a position in Eli Lilly in Q1 2019 and has held it in 29 quarters since.
- 873 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Keudell/Morrison Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.